High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo
Authors:
- 12 April 2023
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 357, 394-403
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01DE026941)
This publication has 41 references indexed in Scilit:
- The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide deliveryAdvanced Drug Delivery Reviews, 2016
- PEGylation as a strategy for improving nanoparticle-based drug and gene deliveryAdvanced Drug Delivery Reviews, 2016
- In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weightNature Nanotechnology, 2014
- Rapid Discovery of Potent siRNA-Containing Lipid Nanoparticles Enabled by Controlled Microfluidic FormulationJournal of the American Chemical Society, 2012
- Comparison of oncolytic adenoviruses for selective eradication of oral cancer and pre-cancerous lesionsGene Therapy, 2010
- Effect of Genome Size on AAV Vector PackagingMolecular Therapy, 2010
- Gene therapy in head and neck cancer: a reviewPostgraduate Medical Journal, 2007
- Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virusThe Journal of Gene Medicine, 2006
- Enhanced Gene Transfer and Oncolysis of Head and Neck Cancer and Melanoma Cells by Fiber Chimeric Oncolytic AdenovirusesClinical Cancer Research, 2006
- Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER databaseInternational Journal of Cancer, 2005